--
The global Cancer/Tumor Profiling market is poised to reach USD 61.87 billion by 2021 from USD 25.82 billion in 2016, at a CAGR of 19.1% from 2016 to 2021. Increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research are the major factors driving the growth of the global Cancer/Tumor Profiling market.
In recent years, the Asia-Pacific market for cancer/tumor profiling has witnessed significant growth due to the rising incidence of cancer, increasing demand for better healthcare services in developing economies such as India and China, rising number of contract research organizations (CROs), and increasing focus of international players on emerging markets.
Complete report on global cancer/tumor profiling market spread across 157 pages, profiling 10 companies and supported with 81 tables and 34 figures is now available at http://www.rnrmarketresearch.com/cancertumor-profiling-market-applications-personalized-medicine-diagnostics-biomarker-discovery-prognosis-research-technologies-ngs-qpcr-ihc-fishcish-microarray-segments-genomics-pr-market-report.html .
In this report, the global Cancer/Tumor Profiling market is segmented on the basis of technology, technique, application, and region. On the basis of technology, the global cancer/tumor profiling market is broadly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immune his to chemistry, and microarray. The next-generation sequencing segment is expected to account for the largest share of the cancer/tumor profiling technology market in 2016. Factors contributing to its largest share include advantages such as reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS.
Furthermore, based on technique, the cancer/tumor profiling market is segmented into genomics, proteomics, epigenetics, and metabolomics. The genomics segment is expected to account for the largest share of the cancer/tumor profiling technique market in 2016. Factors such as increasing investments, grants, and funds by governments; growing research in the field of genomics; and rising application of genomic sequencing in diagnostics are contributing to the growth of this segment.
Based on technology, the global cancer/tumor profiling market is broadly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immune his to chemistry, and microarray. The next-generation sequencing segment is expected to account for the largest share of the cancer/tumor profiling technology market in 2016. Factors such as reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS, and increasing awareness on NGS products and services are contributing to the growth of this segment.
New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.
The Cancer/Tumor Profiling market is dominated by established players such as Illumina Inc. (U.S.), QIAGEN N.V. (Netherlands), NeoGenomics Laboratories (U.S.), HTG Molecular Diagnostic (U.S.), and Genomic Health Inc. (U.S.).
Order a copy of Cancer/Tumor Profiling Market by Application (Diagnostic, Personalized Medicine, Research), Technique (Genomics, Proteomics, Metabolomics, Epigenetics),Technology (Next-generation Sequencing, qPCR, In-situ Hybridization, Microarray)- Forecast to 2021 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=117219 .
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the cancer/tumor profiling market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Inquiry Before Buying on this Report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=117219 .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RnR Market Research
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
Phone: +1-888-391-5441
Website: http://www.rnrmarketresearch.com
Release ID: 152378
Google
RSS